Jin‐Hee Ahn

Tumor-Associated Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

Hee Jin Lee, Jin Young Seo, Jin‐Hee Ahn et al. · Journal of Breast Cancer · 2013 · 139 citations · Full text

Medicine, Immunology, Oncology +17

Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab

Hee Jin Lee, Joo Young Kim, In Ah Park et al. · American Journal of Clinical Pathology · 2015 · 125 citations · Full text

Medicine, Immunology, Oncology +17

Differential expression of major histocompatibility complex class I in subtypes of breast cancer is associated with estrogen receptor and interferon signaling

Hee Jin Lee, In Hye Song, In Ah Park et al. · Oncotarget · 2016 · 102 citations · Full text

Life Sciences, Cancer Biology, Oncology +12

Phase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer

Xavier Pivot, Igor Bondarenko, Zbigniew Nowecki et al. · Journal of Clinical Oncology · 2018 · 100 citations

Medicine, Oncology, Pharmacology +17

Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: relationship to tumor-infiltrating lymphocytes

Hee Jin Lee, Jeong-Ju Lee, In Hye Song et al. · Breast Cancer Research and Treatment · 2015 · 71 citations

Medicine, Immunology, Oncology +17